A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese (Q28943542)

From Wikidata

Jump to navigation Jump to search

scientific journal article

Language	Label	Description	Also known as
English	A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese	scientific journal article

Statements

scholarly article

1 reference

14 March 2017

A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese (English)

1 reference

14 March 2017

genome-wide association study

0 references

1 reference

based on heuristic

inferred from title

Taisei Mushiroda

2

0 references

David Flockhart

9

object named as

David A. Flockhart

1 reference

14 March 2017

6

object named as

Michiaki Kubo

1 reference

14 March 2017

Yūsuke Nakamura

17

object named as

Yusuke Nakamura

1 reference

14 March 2017

Tatsuhiko Tsunoda

3

object named as

Tatsuhiko Tsunoda

1 reference

14 March 2017

Hitoshi Zembutsu

18

object named as

Hitoshi Zembutsu

1 reference

14 March 2017

5

object named as

Naoya Hosono

1 reference

14 March 2017

Takashi Morizono

4

object named as

Takashi Morizono

1 reference

14 March 2017

16

object named as

Mitsunori Sasa

1 reference

14 March 2017

Kazuma Kiyotani

1

object named as

Kazuma Kiyotani

1 reference

14 March 2017

10

object named as

Fuminori Aki

1 reference

14 March 2017

Yuichi Takatsuka

12

object named as

Yuichi Takatsuka

1 reference

14 March 2017

14

object named as

Shozo Ohsumi

1 reference

14 March 2017

Takashi Yamakawa

15

object named as

Takashi Yamakawa

1 reference

14 March 2017

Yusuke Tanigawara

7

object named as

Yusuke Tanigawara

1 reference

14 March 2017

Chiyo K Imamura

8

object named as

Chiyo K. Imamura

1 reference

14 March 2017

author name string

Koichi Hirata

11

1 reference

14 March 2017

Minoru Okazaki

13

1 reference

14 March 2017

publication date

1 April 2012

1 reference

14 March 2017

Human Molecular Genetics

1 reference

14 March 2017

21

1 reference

14 March 2017

1665–1672

1 reference

14 March 2017

7

1 reference

14 March 2017

describes a project that uses

genome-wide association study

1 reference

based on heuristic

inferred from title

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Ultraconserved Elements in the Human Genome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

The DNA sequence and comparative analysis of human chromosome 10

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Ancient noncoding elements conserved in the human genome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

A high-throughput SNP typing system for genome-wide association studies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

A second generation human haplotype map of over 3.1 million SNPs

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Genomic control for association studies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Identifiers

10.1093/HMG/DDR597

1 reference

14 March 2017

1 reference

14 March 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28943542&oldid=2009046713"